Scarica l'app Stockscreener
1.62
8.72%
0.13
Pre-mercato:
1.62
Precedente Chiudi:
$1.49
Aprire:
$1.48
Volume 24 ore:
725.91K
Relative Volume:
0.61
Capitalizzazione di mercato:
$99.45M
Reddito:
$5.03M
Utile/perdita netta:
$-185.41M
Rapporto P/E:
-0.5243
EPS:
-3.09
Flusso di cassa netto:
$-139.79M
1 W Prestazione:
+10.20%
1M Prestazione:
+3.18%
6M Prestazione:
-48.08%
1 anno Prestazione:
-87.96%
Intervallo 1D:
$1.48
$1.62
Intervallo di 1 settimana:
$1.395
$1.62
Portata 52W:
$1.1001
$16.10
Pliant Therapeutics Inc Stock (PLRX) Company Profile
Nome
Pliant Therapeutics Inc
Settore
Industria
Telefono
650-481-6770
Indirizzo
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Confronta PLRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PLRX
Pliant Therapeutics Inc
|
1.62 | 96.38M | 5.03M | -185.41M | -139.79M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.18 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
587.65 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.20 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
708.09 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.91 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-04 | Ripresa | Cantor Fitzgerald | Neutral |
| 2025-03-04 | Downgrade | Needham | Buy → Hold |
| 2025-03-03 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-03-03 | Downgrade | Stifel | Buy → Hold |
| 2025-02-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2025-02-10 | Downgrade | Citigroup | Buy → Neutral |
| 2025-02-10 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-02-10 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-02-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-10 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-09-09 | Ripresa | Leerink Partners | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2023-05-18 | Iniziato | Canaccord Genuity | Buy |
| 2023-04-13 | Iniziato | Robert W. Baird | Outperform |
| 2022-12-14 | Iniziato | Stifel | Buy |
| 2022-12-07 | Iniziato | JP Morgan | Overweight |
| 2022-09-01 | Iniziato | Citigroup | Buy |
| 2022-07-20 | Iniziato | SVB Leerink | Outperform |
| 2022-05-25 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-12-10 | Iniziato | Oppenheimer | Outperform |
| 2021-11-24 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-11-03 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-20 | Iniziato | BTIG Research | Buy |
| 2021-04-05 | Iniziato | Citigroup | Buy |
| 2020-06-29 | Iniziato | Citigroup | Buy |
| 2020-06-29 | Iniziato | Cowen | Outperform |
| 2020-06-29 | Iniziato | Needham | Buy |
| 2020-06-29 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Pliant Therapeutics Inc Borsa (PLRX) Ultime notizie
Pliant Therapeutics Inc.’s volatility index tracking explainedWeekly Investment Summary & Technical Pattern Based Signals - Newser
Will Pliant Therapeutics Inc. Recover After Recent Decline getLinesFromResByArray error: size == 0 - kangso.co.kr
Why Pliant Therapeutics Inc. is moving todayWeekly Profit Report & Advanced Swing Trade Entry Alerts - Newser
How to build a custom watchlist for Pliant Therapeutics Inc.July 2025 Trends & Consistent Profit Trade Alerts - Newser
Sector ETF performance correlation with Pliant Therapeutics Inc.Quarterly Performance Summary & Expert-Curated Trade Recommendations - Newser
How to recover losses in Pliant Therapeutics Inc. stockJuly 2025 Fed Impact & Growth Focused Entry Point Reports - Newser
What machine learning models say about Pliant Therapeutics Inc.2025 Volatility Report & Real-Time Buy Zone Alerts - Newser
Relative strength of Pliant Therapeutics Inc. in sector analysisMarket Growth Summary & Stock Portfolio Risk Management - Newser
How to monitor Pliant Therapeutics Inc. with trend dashboardsJuly 2025 Setups & Technical Confirmation Trade Alerts - Newser
Signal strength of Pliant Therapeutics Inc. stock in tech scannersJuly 2025 Patterns & Weekly Top Stock Performers List - Newser
News impact scoring models applied to Pliant Therapeutics Inc.2025 Trading Recap & Scalable Portfolio Growth Methods - Newser
Is Pliant Therapeutics Inc. forming a reversal patternJuly 2025 PostEarnings & Weekly High Return Opportunities - Newser
Identifying reversal signals in Pliant Therapeutics Inc.Portfolio Update Report & Expert Approved Momentum Trade Ideas - Newser
Pliant Therapeutics Inc. Reaches Critical Trendline SupportQuarterly Profit Report & Daily Entry Point Alerts - 클래시안
Can momentum traders help lift Pliant Therapeutics Inc.Quarterly Investment Review & Weekly Watchlist of Top Performers - Newser
What makes Pliant Therapeutics Inc. stock price move sharplyJuly 2025 Big Picture & Technical Pattern Recognition Alerts - Newser
Is Pliant Therapeutics Inc. a defensive stockFed Meeting & Free Weekly Watchlist of Top Performers - theviewers.co.kr
Will Pliant Therapeutics Inc. stock split in the near futureJuly 2025 News Drivers & Safe Swing Trade Setup Alerts - Newser
Can Pliant Therapeutics Inc. keep up with sector leaders2025 Technical Overview & Expert Approved Momentum Ideas - theviewers.co.kr
Trend Dashboard Flags Pliant Therapeutics Inc. As Potential Swing Trade2025 Volatility Report & Free Community Consensus Stock Picks - beatles.ru
Pliant Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingTrade Risk Summary & Intraday High Probability Setup Alerts - beatles.ru
Is Pliant Therapeutics Inc. forming a bottoming baseOptions Play & Advanced Swing Trade Entry Plans - Newser
Historical volatility pattern of Pliant Therapeutics Inc. visualizedJuly 2025 Short Interest & Breakout Confirmation Trade Signals - Newser
What recovery options are there for Pliant Therapeutics Inc.Earnings Beat & Low Risk Entry Point Guides - Newser
Has Pliant Therapeutics Inc. formed a bullish divergence2025 EndofYear Setup & Proven Capital Preservation Methods - Newser
Using data filters to optimize entry into Pliant Therapeutics Inc.Stop Loss & Weekly High Potential Stock Alerts - Newser
Will Pliant Therapeutics Inc. price bounce be sustainableMarket Sentiment Review & Technical Entry and Exit Alerts - Newser
Using Ichimoku Cloud for Pliant Therapeutics Inc. technicalsWeekly Trend Report & Free Growth Oriented Trading Recommendations - Newser
Ranking Pliant Therapeutics Inc. among high performing stocks via toolsJuly 2025 Short Interest & Weekly Breakout Opportunity Watchlist - Newser
Backtesting results for Pliant Therapeutics Inc. trading strategiesGlobal Markets & AI Driven Price Predictions - Newser
Is now a turning point for Pliant Therapeutics Inc.July 2025 Chart Watch & High Accuracy Investment Entry Signals - Newser
Will Pliant Therapeutics Inc. Sustain Its Chart BreakoutPortfolio Return Report & Weekly High Conviction Ideas - beatles.ru
Using Bollinger Bands to evaluate Pliant Therapeutics Inc.CEO Change & Accurate Intraday Trade Tips - Newser
Short Interest Drops in Pliant Therapeutics Inc. After Rally2025 Support & Resistance & Growth Focused Stock Reports - newsyoung.net
Is Pliant Therapeutics Inc. currently under institutional pressureJuly 2025 Sector Moves & Verified Momentum Stock Ideas - metrotimes.co.kr
Pliant Therapeutics Reports Q2 2025 Financial Results - TipRanks
Citi Maintains Pliant Therapeutics(PLRX.US) With Hold Rating, Maintains Target Price $1.7 - 富途牛牛
How to manage a losing position in Pliant Therapeutics Inc.High Return Trade Roadmap with Setup Filters - Newser
Citi Raises Pliant Therapeutics Price Target to $1.70 Amid Unclear Path Forward - AInvest
Healthcare Sector Analysts Weigh In on Sangamo Biosciences, Pliant Therapeutics, and Zimmer Biomet Holdings - AInvest
Citi Reaffirms Their Hold Rating on Pliant Therapeutics (PLRX) - The Globe and Mail
A Quick Look at Today's Ratings for Pliant Therapeutics(PLRX.US), With a Forecast Between $1.7 to $4 - 富途牛牛
Pliant Therapeutics Pivots To Oncology After Ending IPF Program - Finimize
Pliant Therapeutics shares fall 1.25% intraday after workforce realignment and BEACON-IPF closure. - AInvest
RBC Capital Maintains Pliant Therapeutics(PLRX.US) With Hold Rating, Maintains Target Price $3 - 富途牛牛
Pliant Therapeutics stock price target slashed by Piper Sandler - Investing.com Canada
Needham Maintains Pliant Therapeutics(PLRX.US) With Hold Rating - 富途牛牛
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - 富途牛牛
Pliant Therapeutics Inc Azioni (PLRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Pliant Therapeutics Inc Azioni (PLRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Cummings Keith Lamont | Chief Financial Officer |
Jan 17 '25 |
Sale |
11.20 |
20,148 |
225,680 |
262,608 |
| Hull Hans | Chief Business Officer |
Jan 17 '25 |
Sale |
11.20 |
15,936 |
178,501 |
211,558 |
| Lefebvre Eric | Chief Medical Officer |
Jan 17 '25 |
Sale |
11.20 |
18,478 |
206,974 |
194,574 |
| Cheung Lily | Chief Human Resource Officer |
Jan 17 '25 |
Sale |
11.20 |
3,740 |
41,892 |
24,550 |
| Ouimette Mike | General Counsel & Corp. Sec'y |
Jan 17 '25 |
Sale |
11.20 |
13,270 |
148,639 |
80,774 |
| Ouimette Mike | General Counsel & Corp. Sec'y |
Jan 22 '25 |
Sale |
10.99 |
10,230 |
112,462 |
70,544 |
0.95%
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):